Di Chang, Ji Meng, Li Wenjin, Liu Xiaoyi, Gurung Rijan, Qin Boyang, Ye Shu, Qi Rong
Department of Pharmacology, School of Basic Medical Sciences, Peking University Health Science Center, 38 Xueyuan Road, Beijing, 100191, Haidian District, China.
State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, 100191, China.
Cardiovasc Drugs Ther. 2024 Jun 1. doi: 10.1007/s10557-024-07578-w.
Vascular remodeling is the adaptive response of the vessel wall to physiological and pathophysiological changes, closely linked to vascular diseases. Vascular smooth muscle cells (VSMCs) play a crucial role in this process. Pyroptosis, a form of programmed cell death characterized by excessive release of inflammatory factors, can cause phenotypic transformation of VSMCs, leading to their proliferation, migration, and calcification-all of which accelerate vascular remodeling. Inhibition of VSMC pyroptosis can delay this process. This review summarizes the impact of pyroptosis on VSMCs and the pathogenic role of VSMC pyroptosis in vascular remodeling. We also discuss inhibitors of key proteins in pyroptosis pathways and their effects on VSMC pyroptosis. These findings enhance our understanding of the pathogenesis of vascular remodeling and provide a foundation for the development of novel medications that target the control of VSMC pyroptosis as a potential treatment strategy for vascular diseases.
血管重塑是血管壁对生理和病理生理变化的适应性反应,与血管疾病密切相关。血管平滑肌细胞(VSMC)在这一过程中起关键作用。细胞焦亡是一种程序性细胞死亡形式,其特征是炎症因子过度释放,可导致VSMC表型转化,进而导致其增殖、迁移和钙化,所有这些都会加速血管重塑。抑制VSMC细胞焦亡可延缓这一过程。本综述总结了细胞焦亡对VSMC的影响以及VSMC细胞焦亡在血管重塑中的致病作用。我们还讨论了细胞焦亡途径中关键蛋白的抑制剂及其对VSMC细胞焦亡的影响。这些发现加深了我们对血管重塑发病机制的理解,并为开发以控制VSMC细胞焦亡为潜在治疗策略的新型药物奠定了基础。